ANZ New Zealand Investments, a fund management arm of the bank with $33 billion funds under management, has invested $22 million in cancer diagnostics company, Pacific Edge Limited shares as part of an off-market capital raise.
Pacific Edge created a molecular diagnostic tests most frequently
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
